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Abstract
Rationale, Aims, and Objectives—Huntington Disease (HD) is a progressive genetic brain
disease leading to disruptive cognitive, behavioral, and physical impairments. Persons with the
condition and their caregivers need appropriate and accessible health care services to help them
manage the disease adequately. The purpose of this study was to evaluate the psychometric
properties of a new scale that measures family members' perception of community health care
services (CHCS) for persons with HD.
Methods—A methodological design was used to examine the initial reliability and
dimensionality of the CHCS scale among 245 family members of persons with a diagnosis of HD.
Data analysis consisted of computing Cronbach's alpha coefficients, calculating the 95%
confidence interval for alphas, and performing item-analysis and exploratory factor analysis.
Results—Reliability of the scale based on Cronbach's alpha (α) was .83. Factor analysis using
Principal Component Analysis and Varimax Rotation suggested that three interpretable factors
underlie the scale. Factor 1: HD Knowledge, had α =.82, eigenvalue of 4.67, and explained
33.42% of the variance; Factor 2: HD Community Resources, had α = .62, eigenvalue of 1.68, and
explained 12.02% of the variance; and, Factor 3: Individualized HD Management, had α =.77,
eigenvalue of 1.45, and explained 10.39% of the variance.
Conclusions—Findings from this study provide evidence of both construct validity and internal
consistency reliability of the CHCS scale. Further psychometric testing of the scale in other
samples of family caregivers of persons with HD is warranted.
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HD affects approximately three to seven per 100,000 people of western European descent.1
HD is characterized by progressive loss of motor, emotional, and cognitive functions.
Although historically considered a movement disorder, it is now well accepted that
psychiatric disorders, cognitive dysfunction, and psychomotor impairments often precede
the clinical diagnosis based on motor exam.2,3 All cases can be confirmed with a positive
genetic test of the abnormal expansion of CAG repeats in the HD gene (IT 15) on the short
arm of chromosome four.4 The average age of symptom onset is in the fourth decade of life,
3 and the condition is characterized by progressive degeneration over 10-25 years.5
Family members who served as support persons during predictive testing of an at-risk
person often report symptoms of HD in those with the gene mutation, between the time of a
positive gene test result and clinical diagnosis.6 In addition, concerns about changes in
behavioral functioning are a common theme among family members whose spouses or adult
children were in the pre-manifest stage of HD.7 In addition, family caregivers for persons
with HD have other concerns including practical aspects of caregiving, satisfaction with life,
and feelings about living with HD as being relevant to their carers' quality of life.8 Family
caregivers also may be concerned about disintegration of the caregiver's life, the loss of the
relationship with the person with HD, and heritability of risk for the disease among
biologically related family members.9(unpubl. Observ.) When there is a family member with a
chronic illness, caregiving by family involves the caregiver, the family, and their health care
environments.10 Researchers have documented distress in partners of persons receiving a
positive predictive HD test,11,12 and distress may reflect not only feelings of loss and grief
but also thoughts regarding the future role as a caregiver.13
Family caregivers of persons with Huntington Disease (HD) are faced with increasingly
stressful situations, which reflect their loved one's needs for psychological and physical care.
These stressful situations have the potential for harmful effects on caregivers' health and
wellbeing.14-16 Despite extensive research in caregiving, most studies have focused on
family caregivers of the elderly and have not included populations in which
neurodegenerative conditions such as Huntington Disease (HD) that occur earlier in the life
span. Caregivers who are depressed have a higher risk for caregiver burden and
acompromised belief in his/her ability to solve problems.17 Among multiple sources of
emotional distress in family caregivers is the ongoing pattern of losses of personal goals and
functions in the person with HD. This pattern may influence the abilities of families to
proactively prepare for changes in managing the person's care and using health care services.
9(unpubl. observ.) Challenges facing family of persons with HD and those who are their
primary caregivers include the availability of adequate health care services resources.17
However, existing measures do not address community health care services resources to
support these family members.
Many persons with HD live in their homes or in a family member's home in the community
until the family can no longer manage their care. Persons with HD and their family members
need appropriate and accessible day-to-day health care services to help them cope with and
manage the disease. However, no measures of family members' perception of health care
services for persons with Huntington Disease were found. Thus, a new measure of
Community Health Care Services (CHCS) for family of persons with HD was developed
and fully described elsewhere.18(unpubl. observ.) This instrument was developed from a larger
parent study whose purpose was to identify concerns of family members of persons with HD
and strategies used to manage these concerns.19 The parent study used a mixed methods
design in which common themes were identified from focus groups with 91 adult family
members at six sites in the US and Canada, and a survey was constructed from the themes
Sousa et al. Page 2













and focus group statements.18(unpubl. observ.) The purpose of this component of the study is
to evaluate the psychometrics of the Community Health Care Services scale of the
Huntington Disease Family Concerns and Strategies Survey (HDFCSS).18(unpubl. observ.)
The scale was evaluated for internal consistency, dimensionality, and construct validity.
Establishing the validity and reliability of this instrument with the targeted study group is
necessary for further research and for examining the utility of this measure to assess
components of community health care services to support HD families.
Materials and Methods
Research Design
In accordance with suggestions made by Burns and Grove,20 a methodological design was
used to examine the initial reliability and dimensionality of the CHCS scale among family
members of persons with HD.
Sample and Setting
A purposive sample of 245 family members of persons with HD participated in this study.
The sample was recruited through the Iowa HD Registry, the HD Lighthouse, The
University of Iowa HD Center of Excellence, and the University of Connecticut Health
Center. The inclusion criteria were adult family members of a person with HD who had the
ability to read, write, and understand English. The sample size of 245 subjects was sufficient
to examine the initial psychometric properties of the 14-item CHCS scale, based on
recommendations of at least 5-10 subjects per item of an instrument.21-23 The Kaiser-
Meyer-Olkin results of .82, which exceeded the recommended value of .60 to proceed with
exploratory factor analysis, also indicated that the sample size was adequate.24 The
characteristics of the sample of family members and care recipients are shown in Table 1.
Instruments
A demographic questionnaire developed by the researchers was used to collect background
information on family members (e.g., age, gender, ethnicity, educational level, marital
status, and relationship with care recipient). The Community Health Care Services (CHCS)
scale was used to measure family members' perceptions of the availability of adequate
community resources to support health care of the person with HD. This instrument was
developed by the research team, and its face and content validity are reported elsewhere.
18(unpubl. observ.) Briefly, focus groups, literature review, and examination of other
instruments were used to compose the items of the scale. The scale has 14 items. Each item
of the scale ranged from 0 (I do not know/not applicable) to 4 (strongly agree). Higher
scores mean better agreement that each statement describes available and adequate
community health care services. Nine clinical experts (health care providers or researchers
with expertise in medicine, neuropsychology, management of HD, caregiving, and
qualitative methodology) rated the content validity of a 7-item scale that was initially
developed. Clinical experts used a four-point Likert-type scale ranging from “1 = Not
Relevant” to “4 = Very Relevant” to assess the relevance of the items. Only 3 of 7 initial
items of the CHCS scale achieved the minimum criteria of I-CVI ≥ 0.78.25 The CHCS
overall scale (S-CVI/Ave) was .79, not exceeding the minimum recommendation of S-CVI/
Ave of .90.26 As stated above, to address the scale content validity, focus groups, cognitive
interviewing, literature review, and examination of other instruments were used to further
revise and compose the items of the scale.
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The Institutional Review Boards at each institution approved the study. As described
elsewhere18(unpubl. observ.) the researchers used the Dillman's method27 for mailing research
instruments to family members of persons with HD. Briefly, the method included mailing an
announcement with a reply form and postage paid envelope. Upon receipt of the reply form,
a research package including a specific demographic questionnaire, the survey, and a
detailed letter with information about the purpose, benefits, and risks involved in
participating in the study, was mailed to the participants. If the research package was not
returned in two weeks, a reminder letter was sent. If no response was received within three
weeks, a second research package was mailed. Persons who returned the research package
received a “Thank You Letter” and a $20.00 telephone card. Of 390 research packages
mailed, 269 (70%) were returned. However, only 245 research packages were used in the
data analysis because of missing data. These missing data were from blank questionnaires,
and some persons indicated that they were the proband, rather than a family member. Data
were collected from March to November, 2006. Data were entered into an Excel 2003
spread sheet and double-checked by two research team members. The raw data set was then
imported into the Statistical Package of the Social Science (SPSS) 14.0 (Chicago, Illinois),
which was used to conduct data screening, cleaning, coding, and the analysis.
Data Analysis
Descriptive statistics were used to characterize the sample of family member respondents
(e.g., frequencies, percentages, mean, and standard deviation) as appropriate for the level of
the data. Psychometric analysis of the CHCS scale consisted of computing Cronbach's alpha
coefficient, the 95% confidence interval for alpha, and item-analysis (computing inter-item
correlations and item-to-total correlations) to determine its internal consistency and
homogeneity. Exploratory factor analysis was also conducted to establish the dimensionality
and construct validity of the scale.
Results
Internal Consistency and Homogeneity
The overall estimate of reliability of the CHCS scale was Cronbach's alpha = .83 (.95 CI = .
80 - .86). This reliability estimate exceeded the minimum recommended criteria for
determining internal consistency for new scales (Cronbach's alpha of at least .70).22
Deletion of any one of these items did not improve the overall Cronbach's alpha coefficient
of the scale; the coefficient of reliability continued to be very close or equal to the reported
Cronbach's alpha (α ranging from .81 to .83), which meets the minimum criteria for internal
consistency.22 Inter-item correlations of the scale ranged from .04 to .82 (mean = .26). In
addition, as shown in Table 2, all but two of the item-to-total score correlations for each
factor were between r = .30 and r = .70, except for item 4 (factor 2) and item 6 (factor 1).
These findings suggest the need for revision or deletion of these items to meet the necessary
recommended criterion for scale homogeneity.28
Dimensionality and Construct Validity
A principal components factor analysis with varimax rotation was conducted on the CHCS
scale items. This method was used to extract the minimum number of factors that explain
the maximum variance of the items of the new scale. The Scree Plot (Figure 1) clearly
suggested that three interpretable factors underlie the items of the scale. As seen in Table 2,
factor 1: HD Knowledge had α =.82 (.95 CI = .78 - .85), eigenvalue of 4.67, and explained
33.42% of the items variance of the scale. Factor 2: HD Community Resources had α = .62
(.95 CI = .53 - .70), eigenvalue of 1.68, and explained 12.02% of the items variance of the
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scale. In addition, factor 3: Individualized HD Management had α = .77 (.95 CI = .70 - .82),
eigenvalue of 1.45, and explained 10.39% of the items variance of the scale. All factor
loadings exceeded the minimum recommended criteria of .30.22,29 All communality values
were above .30 as recommended by Tabachnick and Fidell24 except for item 6 and item 14,
which had communalities of .13 and .23, respectively.
Discussion and consensus agreement among members of the research team defined the
theme of each factor. Items in Factor 1 (HD Knowledge) reflect understanding of HD by
health care providers and people in the community. Items in Factor 2 (HD Community
resources) reflect services to support caregiving for persons with HD such as home health,
day care, assisted living, and nursing homes. Factor 3 (Individualized HD Management)
reflects the extent to which health care considers the person's holistic health care needs
rather than being limited to symptoms associated with HD. Titles of each factor were
developed after discussion and consensus agreement among the investigators.
Discussion
Community health care services are critical to support family who are primary caregivers of
persons with HD or who participate in their care. This study conducted a psychometric
evaluation of a scale that measures family members' perception of community health care
services for persons with HD. The findings support the internal consistency of the scale. The
Cronbach's alpha of .83 (0.95 CI= .80 - .86) for the total scale exceeded the recommended
coefficient of internal consistency of Cronbach's alpha set at .70.22 Factor analysis
suggested a three-factor structure scale, however, one of the subscales (factor 2), which has
3 items, had a Cronbach's alpha below .70. In addition, since not all item-to-total score
correlations for each factor were between r = .30 and r = .70, a revision of the instrument
would likely meet the recommended criterion for scale homogeneity.28 This should improve
the internal consistency and homogeneity of the scale and subscales. We encourage
clinicians and researchers who want to use the scale to do so, but we recommend further
evaluation of the scale homogeneity and internal consistency based on their sample.
Family of persons with HD in the US may receive health care from specialists in HD care,
such as those found in the Centers of Excellence supported by the Huntington Disease
Society of America, and all will receive some health care services from community based
health care providers. Community providers include those providing primary care, home
health care, adult day care, assisted living facilities, and nursing homes. Factor analysis and
prior validity testing establish the CHCS scale as a multidimensional and psychometrically
sound community health care services assessment tool that incorporates three aspects of
family member perceptions of health care services including provider knowledge of HD,
community services, and individualized management of HD. Existing community based
services may be a poor fit for the persons with HD and their families due to multiple
symptoms in HD and the rarity of the condition. When services for persons with neurologic
function loss exist, they may not fit the needs of young or middle-aged adults who need
home based or community based health services. In addition to persons with HD, other
examples are persons with severe traumatic brain injury30 and persons with brain tumors.31
If modified to reflect the specific diagnosis, this tool may identify those aspects of
community based health care services that are most salient to other clinical populations.
Although socioeconomic status (SES) was not estimated in our sample, education is
commonly used as a proxy for SES.32 It is notable that over 75% of our sample had
completed post-secondary education, suggesting that this sample has the capacity to identify
and evaluate adequate resources. In addition, in many chronic conditions, the majority of
caregivers among family members are found to be female.33-35 This was true in the sample
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responding to the survey, with a female/male ratio of approximately 2:1, and many of them,
slightly fewer than 50%, lived in urban areas. Approximately half of the respondents
identified themselves as primary caregivers. Thus, the sample represented greater diversity
regarding location and responsibility, with less variability regarding SES and ethnicity. It
will be important to consider the potential influence of demographic characteristics when the
instrument is used in other populations.
Availability of adequate resources to support the care of persons with HD is distinct from
the construct of Quality of Life (QOL). Quality of life can refer to a person's subjective
experience of life and may include biological function, symptoms, functional status, and
general health perception.36 For a persons with HD, QOL can be distinct from severity of
illness,37 QOL for caregivers has been found to address a wider range of concepts as
measured by the Quality of Life Battery for Carers (HDQoL-C) developed by Aubeeluck
and Buchanan.8 Both types of scales are needed for this population.
Conclusion
Findings from this study provide evidence of the validity and reliability of the data collected
from this sample using the CHCS scale to measure HD family members' perception of
community health care services in the US. Although for most part, the scale has met for the
most part the recommended criteria for construct validity, internal consistency, and
homogeneity, further psychometric testing of the scale in other samples of family caregivers
of person with HD is warranted. We believe the psychometric properties of the CHCS scale
are supportive of its use in current research. However, we realize it could be improved with
the addition of new items and the revision of two of the items. The scale can be useful in
research and clinical practice to determine adequacy of community health care services to
support family and family caregivers of persons with HD.
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CHCS's Factor Analysis Scree Plot
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Table 1
Sample Characteristics (N =245)
Variable N % M SD
Age 45.0 14.1
Country of Residence
United States 242 98.8
Other 3 1.2
Ethnicity
Non-Hispanic White 228 93.2
Native American 5 2.0
Hispanic 6 2.4





Less than High School 10 4.1
High School 47 19.2
Associate Degree 77 31.4
Baccalaureate Degree or Above 110 45.0






No response 22 8.9
Relationship with Care Recipients













No Response 3 1.2
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Variable N % M SD
Age of Care Recipients 50.8 13.3
Place Care Recipient Lives
Caregivers' Home 93 38.0
Care recipients' home 87 35.5
Nursing Home 32 13.1
Assisted Living Facility 10 4.1
No response 20 8.1
Health Care Services Access
Huntington Disease Center 41 16.7
Family Physician 46 18.8
Neurologist 31 12.7
Psychologist 02 .8
Multiple Providers 114 46.3
No response 11 4.6
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